Fierce Medical Devices

Subscribe to Fierce Medical Devices feed
Updated: 6 hours 17 min ago

Eisai’s prototype blood test for Alzheimer’s shows links to CSF amyloid in early disease

8 hours 39 min ago
New research from Eisai showed measurable correlations between amyloid biomarkers in the bloodstream and changes in the cerebrospinal fluid, bringing the company a step closer to developing a quick and simple blood test for Alzheimer’s disease.

Musk's Neuralink startup aims to connect brains to the web, starting next year

Wed, 07/17/2019 - 07:36
Elon Musk pulled back the curtain on his brain interface-developing Neuralink in a technology showcase aimed more at recruiting new employees to the secretive company than attesting to its science.

Yale, Mayo Clinic tap Biofourmis’ sensors and the new Apple Watch to study digital endpoints for heart disease

Tue, 07/16/2019 - 11:59
Could wearable biosensors change the face of clinical trials and shorten a drug’s regulatory journey? That’s what Yale University and the Mayo Clinic are trying to find out, using biosensors and Biofourmis’ mobile health platform.

GNS Healthcare's AI patient-matching platform nets $23M from Cigna Ventures, Amgen, Celgene

Tue, 07/16/2019 - 11:14
GNS Healthcare has raised $23 million from the venture capital arms of drugmakers and health insurance companies to build out its artificial-intelligence-driven precision medicine platform.

Paragon's new company to carry its AI-powered breast cancer diagnostic buy

Tue, 07/16/2019 - 08:56
Life sciences incubator Paragon Biosciences has built a new portfolio company around its acquisition of the first FDA-cleared artificial intelligence system for diagnosing breast cancer.

Notable Labs lands $40M to expand AI-based cancer treatment tech

Mon, 07/15/2019 - 19:36
Notable Labs is adding $40 million to its reserves as it scales up its artificial-intelligence-based drug discovery technology with plans to take its platform worldwide.

FDA approves Bayer's Gadavist MRI agent to help spot coronary artery disease

Mon, 07/15/2019 - 08:49
The FDA approved Bayer’s Gadavist MRI contrast agent to help gauge the blood supply of the heart muscle.

AI drug prospector Recursion Pharma nets $121M for its clinical programs

Mon, 07/15/2019 - 07:44
Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new financing for its artificial intelligence programs.

GE Healthcare recalls 25,000 hospital infant warmer beds due to cracking safety latches

Mon, 07/15/2019 - 07:08
GE Healthcare has recalled two of its infant warmers—bedlike hospital devices designed to radiate heat and track the health of newborns—due to side panels and latches that may crack, break or open, allowing infants to fall.

FDA clears Abbott IVD system for screening blood, plasma donations

Fri, 07/12/2019 - 10:59
Abbott has received FDA approval for a new addition to its Alinity line of laboratory diagnostic hardware designed to screen blood and plasma donations for potential contaminants.

Encore: Orchestra BioMed quickly nets another $34M for its cardiovascular pipeline

Fri, 07/12/2019 - 07:35
Hot on the heels of its international distribution deal with Terumo, Orchestra BioMed has secured $34 million in new funding for its devices aimed at high blood pressure and blocked arteries.

Oops—Layoffs of lab staff at uBiome force the company to halt sample testing: reports

Thu, 07/11/2019 - 08:33
A fresh round of layoffs at the struggling and scrutinized uBiome has left the at-home sequencing test provider without a lab director and other key staff—and with them, its ability to provide an at-home sequencing test.

Trump orders overhaul of kidney disease payments and treatment

Wed, 07/10/2019 - 09:34
The Trump administration has put forward an executive order designed to incentivize at-home kidney dialysis, potentially affecting tens of thousands of people who undergo the procedure at commercial clinics.

23andMe therapeutics leader leaves for board roles at up-and-coming biotechs

Wed, 07/10/2019 - 07:29
23andMe’s chief scientific officer and former therapeutics foreman Richard Scheller has left the sequencing company and landed on the boards of at least two biotechs—namely, two of the biggest money raisers of the year so far.

Fierce 15 winner AblaCare raises €10M for PCOS infertility treatment

Tue, 07/09/2019 - 12:09
FierceMedTech Fierce 15 winner AblaCare, developer of a device-based approach to treating infertility associated with polycystic ovarian syndrome, has secured €10 million ($11.2 million) in its first major venture capital haul.

Eisai launches first startup incubator under its genomics center for dementia

Tue, 07/09/2019 - 07:29
Eisai opened its first startup incubator as part of its new Cambridge, Massachusetts-based center focused on exploring the genetic links to dementia and potential immunotherapies.

Fresenius to restructure global R&D efforts under its Frenova arm

Mon, 07/08/2019 - 08:01
Dialysis giant Fresenius Medical Care announced plans to expand its work in international clinical research, elevating its North America-centric Frenova research subsidiary to the global stage.

Searching exhaled breaths for the chemical signs of multiple sclerosis

Mon, 07/08/2019 - 06:47
Researchers at the University of Huddersfield in England hope to collect and screen the thousands of organic compounds exhaled with each breath for signs linked to multiple sclerosis.

AgaMatrix raises $56M to develop and sell its WaveForm CGM

Mon, 07/08/2019 - 06:41
The diabetes diagnostic-focused AgaMatrix has secured a capital raise of about $56 million, with plans to support clinical trials of a continuous glucose monitoring system being developed under its WaveForm Technologies subsidiary.

Sernova touts first-in-human results from insulin-secreting cell implant for diabetes

Wed, 07/03/2019 - 07:37
In the first patient to receive its pancreatic cell implant for type 1 diabetes, Sernova’s insulin-secreting Cell Pouch showed no adverse events related to the therapy, and was able to help maintain blood sugar levels over at least two weeks.